A Japanese case report of co-localized psoriasis and vitiligo reveals that IL-23 blockade cleared psoriasis but not vitiligo, ...

Everyday Health shares their favorite psoriasis organizations to help you educate yourself, spread awareness, and connect ...

There’s an interesting relationship between psoriasis and exercise: While the condition can make playing sports and working ...

Since the drug’s approval and launch earlier this year, J&J has recorded more than 20,000 patient starts on Icotyde, funneled ...

Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...

New drive to improve care for Psoriasis patients launched in Harrogate ...

Zasocitinib demonstrated superiority over deucravacitinib for the treatment of moderate to severe plaque psoriasis, according ...

Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

A national analysis of US ambulatory care visits finds patients with psoriasis have more than eightfold increased odds of ...

Age alone should not dictate biologic hesitancy. The panel challenges the assumption that systemic therapies are inherently riskier in older adults, pointing to safety data and the realities of ...

A 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.

The global burden of acne increased from 1990 to 2023 and is set to continue increasing through 2050, according to a study ...